Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development UpdatesGlobeNewsWire • 07/26/22
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 07/11/22
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/23/22
Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare ConferenceGlobeNewsWire • 02/02/22
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial MyopathiesGlobeNewsWire • 09/28/21
Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare ConferenceGlobeNewsWire • 05/19/21
Biotech Stocks: 14 Things to Know as the VECT Stock IPO and RPHM Stock IPO Begin Trading TodayInvestorPlace • 04/09/21